Andrew Merken and Josef Volman hosted a panel discussion and Q&A about the state of Life Sciences M&A and VC financing activity in the current climate of COVID-19. The Investment Banker/VC Investor panel discussed how the pandemic is impacting M&A activity and VC financing as to deal terms, valuations, deal timelines, and deal activity. They also addressed the outlook for the rest of 2020 and future trends.
receive news & alerts
Yes! I’d like to receive updates with firm news and insights that are relevant to me!